Effectiveness of a hepatitis A vaccination program for migrant children in Amsterdam, The Netherlands (1992-2004)

Vaccine

Volumn 24, Issue 23, 2006, Pages 4962-4968

  Sonder, G J B ^a,b   Bovee L P M J ^a   Baayen, T D ^a   Coutinho, R A ^a,c   van den Hoek, J A R ^a  

^a MUNICIPAL HEALTH SERVICE   (Netherlands)

^b LCR   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Epidemiology; Hepatitis A; Migrant children; Risk group; Vaccination

Indexed keywords

HEPATITIS A VACCINE;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG SCREENING; DRUG TARGETING; DRUG USE; ENDEMIC DISEASE; EXPOSURE; HEALTH PROGRAM; HEPATITIS A; HIGH RISK POPULATION; HUMAN; IMMUNITY; INCIDENCE; INJECTION; MAJOR CLINICAL STUDY; MIGRATION; NETHERLANDS; POPULATION RESEARCH; PRIMARY SCHOOL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRAVEL; VACCINATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; EMIGRATION AND IMMIGRATION; HEPATITIS A; HEPATITIS A VACCINES; HUMANS; IMMUNIZATION PROGRAMS; INFANT; MOROCCO; NETHERLANDS; TIME FACTORS; TURKEY;

EID: 33646893859     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.03.075     Document Type: Article

References (26)

1. Diel R., and Schneider S. Transmission of hepatitis A in Hamburg, Germany, 1998-1999-A prospective population based study. Eur J Epidemiol 17 (2001) 175-182
2. Craig A.S., and Schaffner W. Prevention of hepatitis A with the hepatitis A vaccine. N Engl J Med 350 (2004) 476-481
3. Nainan O.V., Armstrong G.L., Han X.H., Williams I., Bell B.P., and Margolis H.S. Hepatitis a molecular epidemiology in the United States, 1996-1997: sources of infection and implications of vaccination policy. JID 191 (2005) 957-963
4. Nordenfeldt E. Hepatitis A in Swedish travellers. Vaccine 10 (1992) S1 p. S73-4
5. Sonder G.J.B., van Steenbergen J.E., Bovée L.P.M.J., Peerbooms G.H., Coutinho R.A., and van den Hoek J.A.R. Hepatitis A virus immunity and seroconversion among contacts of acute hepatitis A patients in Amsterdam 1996-2000: an evaluation of current prevention policy. Am J Public Health 94 9 (2004) 1620-1626
6. van Gorkom J., Leentvaar-Kuijpers A., Kool J.L., and Coutinho R.A. Association between the yearly hepatitis A epidemic and travel behaviour of children of immigrants in the four major cities of The Netherlands. Ned Tijdschr Geneesk 34 (1998) 1919-1923 [article in Dutch]
7. Termorshuizen F., and van de Laar M.J. The epidemiology of hepatitis A in the Netherlands, 1957-1998. Ned Tijdschr Geneeskd 142 43 (1998) 2364-2368 [article in Dutch]
8. van Steenbergen J.E., Tjon G., van den Hoek A., Koek A., Coutinho R.A., and Bruisten S.M. Two years' prospective collection of molecular and epidemiological data shows limited spread of hepatitis A virus outside risk groups in Amsterdam, 2000-2002. J Infect Dis 189 3 (2004) 471-482
9. Landelijk Coordinatiecentrum Reizigersadvisering. (National Coordination Center for Travelers Health Advice): National guideline for Hepatitis A vaccination for travelers [in Dutch].
10. Annual Reports 1998-2004. Department Infectious Diseases, GG&GD Amsterdam, The Netherlands. In: Bovée LPMJ, Leentvaar-Kuijpers A, van den Hoek JAR, editors.
11. Landry P., Tremblay S., Darioli R., and Genton B. Inactivated hepatitis A vaccine booster given ≥24 months after the primary dose. Vaccine 19 45 (2000) 399-402
12. Gemeente Amsterdam, Dienst Onderzoek en Statistiek: Amsterdam in cijfers, jaarboek 2004. November 2004. ISBN 90 6274 1320 [in Dutch].
13. Postma J., Bos J.M., Beutels Ph., Schilthuis H., and van den Hoek J.A.R. Pharma-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands). Vaccine 22 (2004) 1862-1867
14. In: Bovée LPMJ, van den Hoek JAR, editors. Annual Report 2003. Amsterdam, The Netherlands: Department Infectious Diseases, GG&GD.
15. Termorshuizen F., Dorigo-Zetsma J.W., De Melker H.E., van den Hof S., and Conyn-van Spaendonck M.A.E. The prevalence of antibodies to hepatitis A virus and its determinants in The Netherlands: a population-based survey. Epidemiol Infect 124 (2000) 459-466
16. Richardus J.H., Vos D., Veldhuijzen I.K., and Groen J. Seroprevalence of hepatitis A virus antibodies in Turkish and Moroccan children in Rotterdam. J Med Virol 72 2 (2004) 197-202
17. Dijkshoorn H., Schilthuis H.J., van den Hoek J.A.R., and Verhoeff A.P. Travel advice on the prevention of infectious diseases insufficiently obtained by indigenous and non-native inhabitants of Amsterdam, The Netherlands. Ned Tijdschr Geneeskd 147 14 (2003) 658-662 [article in Dutch]
18. Bell PB. Global epidemiology of hepatitis A: implications for control strategies. 10th International Symposium on Viral Hepatitis and Liver Disease. 2002 International Medical Press. http://www.cdc.gov/ncidod/diseases/hepatitis/a/global_hepA_epi.pdf, accessed 10 April 2006.
19. Nejmi S., Coursaget P., D'Khissy D., Barres J.L., and Chiron J.P. Prévalence des infections par les virus des hépatites A et B au Maroc. La Presse Médicale 13 29 (1984) 1786-1787.
20. Kanra G., Tezcan S., Badur S., and Turkish National Study Team. Hepatitis A seroprevalence in a random sample of the Turkish population by simultaneous EPI cluster and comparison with surveys in Turkey. Turk J Pediatr 44 3 (2002) 204-210
21. den Exter J. Regional origin of Turkish migrants in The Netherlands. Migrantenstudies 9 3 (1993) 18-34 [article in Dutch]
22. Haks K., van Kessel R.P.M., Schout C., Zeller M., and van Ameijden E.J.C. Travelling and vaccination behaviour in Utrecht, The Netherlands: trends. Infectieziektenbulletin 16 5 (2005) 167-170 [article in Dutch]
23. World Health Organization. Hepatitis B prevalence. http://www.who.int/vaccines-surveillance/graphics/htmls/hepbprev.htm; 1996.
24. World Health Organization. Hepatitis A prevalence. http://www.who.int/csr/disease/hepatitis/whocdscsredc2007/en/index1.html#world.
25. Health Council of the Netherlands. Universal vaccination against hepatitis B. The Hague: health council of the Netherlands; 2001; publication no. 2001/03. www.gr.nl/pdf.php?ID=187.
26. Steenbergen J.E., Leentvaar-Kuijpers A., Baayen D., Dukers H.T.M., van Doornum G.J.J., van den Hoek J.A.R., et al. Evalution of the hepatitis B antenatal screening and neonatal immunization program in Amsterdam, 1993-1998. Vaccine 20 (2001) 7-11